Cambieri C

References (2)

Title : Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study - Ceccanti_2022_Front.Pharmacol_13_982434
Author(s) : Ceccanti M , Libonati L , Ruffolo G , Cifelli P , Moret F , Frasca V , Palma E , Inghilleri M , Cambieri C
Ref : Front Pharmacol , 13 :982434 , 2022
Abstract : Ceccanti_2022_Front.Pharmacol_13_982434
ESTHER : Ceccanti_2022_Front.Pharmacol_13_982434
PubMedSearch : Ceccanti_2022_Front.Pharmacol_13_982434
PubMedID: 36052140

Title : Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation - Trebbastoni_2012_Clin.Neurophysiol_123_902
Author(s) : Trebbastoni A , Gilio F , D'Antonio F , Cambieri C , Ceccanti M , de Lena C , Inghilleri M
Ref : Clin Neurophysiol , 123 :902 , 2012
Abstract : Trebbastoni_2012_Clin.Neurophysiol_123_902
ESTHER : Trebbastoni_2012_Clin.Neurophysiol_123_902
PubMedSearch : Trebbastoni_2012_Clin.Neurophysiol_123_902
PubMedID: 21996001